SuperworthJourney Medical profit margin DERM
Gross, operating and net profit as a share of revenue over the last twelve months, from 2021.
- Net margin, 12 months
- −9.0%
- Operating margin, 12 months
- −4.4%
- Net margin on a year earlier
- +6.5 pts
- Peer median
- 11.6%
Over the twelve months to Jun 30, 2026, Journey Medical kept −9.0% of its revenue as net profit, with an operating margin of −4.4% and a gross margin of 65.5%.
Five years earlier its net margin was −18.4%.
The median for 10 large drugmakers of a similar size is 11.6%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −18.5% | −13.2% | 66.2% |
| FY2024 | −26.1% | −24.4% | 62.8% |
| FY2023 | −4.9% | −2.6% | 66.3% |
| FY2022 | −40.2% | −37.4% | 58.2% |
| FY2021 | −69.7% | −55.2% | 49.2% |
| FY2020 | n/a | n/a | n/a |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −9.0% | +6.5 pts | −4.4% | |
| Q1 FY26 | −14.8% | −0.1 pts | −9.8% | |
| Q4 FY25 | −18.5% | +7.7 pts | −13.2% | |
| Q3 FY25 | −14.6% | +17.2 pts | −9.3% | |
| Q2 FY25 | −15.5% | −16.6 pts | −12.2% | |
| Q1 FY25 | −14.8% | −9.6 pts | −12.3% | |
| Q4 FY24 | −26.1% | −21.3 pts | −24.4% | |
| Q3 FY24 | −31.7% | −16.3 pts | −31.2% | |
| Q2 FY24 | 1.1% | +64.9 pts | 2.7% | |
| Q1 FY24 | −5.2% | +56.1 pts | −3.3% | |
| Q4 FY23 | −4.9% | +35.4 pts | −2.6% | |
| Q3 FY23 | −15.5% | +38.7 pts | −12.5% |
Against its peers
Companies in Drug Manufacturers - General nearest Journey Medical's size, closest first, today.
| Company | Profit margin |
|---|---|
| DERMJourney Medical | −9.0% |
| NATRNatures Sunshine Products | 3.7% |
| LFVNLifevantage | 2.8% |
| SPROSpero Therapeutics | 15.7% |
| ATNMActinium Pharmaceuticals | n/m |
| ARVNArvinas | 2.9% |
| PBYIPuma Biotechnology | 11.6% |
| IRWDIronwood Pharmaceuticals | 33.4% |
| ZVRAZevra Therapeutics | 42.8% |
| CRMDCorMedix | 40.5% |
| COLLCollegium Pharmaceutical | 5.9% |
| Peer median | 11.6% |
Where Journey Medical ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Journey Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.